Immunotherapy and metastic renal cell cancer.
Buzio
C
C
De Palma
G
G
Caminiti
C
C
Cattabiani
M A
MA
Manenti
L
L
D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D011994:Recombinant Proteins; D013997:Time Factors
D007370:Interferon Type I; D007376:Interleukin-2; D011994:Recombinant Proteins